June 19, 2017 - June 22, 2017
San Diego, CA
Panelist: Roger Longman
Real Endpoints LLC
Value assessment frameworks are a relatively new concept designed to help stakeholders determine what treatments provide the most value in healthcare. They are sometimes influential in determining what therapies are chosen by patients and their doctors, and often used to determine if those therapies will be covered and reimbursed by payers. How these frameworks consider personalized medicine is not yet clear. Designed before 25% of all new drugs were personalized medicines, value frameworks might need to evolve to keep pace with scientific discovery and recognize the leading role of diagnostic testing in targeting therapeutic use. This session will examine how value assessment frameworks have been developed historically, examine the current critiques of their processes and methodologies and explore how they might have to change in the future to support personalized medicine.
view event >January 7, 2024
San Francisco, CA
Jeff Berkowitz, CEO
Real Endpoints
Real Endpoints CEO, Jeff Berkowitz to be participating in the Sachs NIF at JPM24. Given the level of innovation in CNS, it’s a timely discussion.
November 17, 2023
Chicago, IL
Rob O'Brien, SVP Specialty
A day-long meeting in Chicago focused on healthcare and pharmaceutical marketplace trends, including a review of the specialty pipeline, implications of the IRA, and potential pharmaceutical disruptions. Rob O’Brien, SVP of Specialty, presenting.
October 19, 2023 - October 20, 2023
Las Vegas, NV
Jane Barlow, Chief Clinical Officer
A meeting of healthcare executives representing integrated delivery networks, managed care nurses, and medical directors.
October 18, 2023 - October 20, 2023
New York, NY
Susan Raiola, President
Stakeholders in the cancer care ecosystem meet to discuss issues linked to cost, quality, and access. RE President, Susan Raiola, will be speaking on patient support.
October 10, 2023 - October 12, 2023
Orlando, FL
Rob O'Brien, SVP Specialty
Pharma and payer execs gather to discuss the future of managed care pharmacy. Rob O’Brien provides a perspective on the self-insured employer market.
October 8, 2023 - October 10, 2023
Carlsbad, CA
Roger Longman, Co-Founder and Chairman
Top biotech CEOs gather from around the globe to discuss pressing industry issues. Roger Longman, Co-founder and Chairman, is participating.
Manager
Payer & Channel Insights, Marketing Analytics & Business Insights